Metabolic Syndrome and Psoriasis: Mechanisms and Future Directions
Psoriasis is an immune-mediated systemic disease with associated comorbidities, including metabolic syndrome (MetS) which contributes substantially to premature mortality in patients with psoriasis. However, the pathological mechanisms underlying this comorbidity are unclear. Studies have shown that...
Main Authors: | Yan Hao, Ya-juan Zhu, Song Zou, Pei Zhou, Ya-wen Hu, Qi-xiang Zhao, Lin-na Gu, Hao-zhou Zhang, Zhen Wang, Jiong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.711060/full |
Similar Items
-
Gut Microbiota Dysbiosis and Altered Bile Acid Catabolism Lead to Metabolic Disorder in Psoriasis Mice
by: Hao, Y., et al.
Published: (2022) -
Skin and Gut Microbiome in Psoriasis: Gaining Insight Into the Pathophysiology of It and Finding Novel Therapeutic Strategies
by: Lihui Chen, et al.
Published: (2020-12-01) -
Deciphering Gut Microbiota Dysbiosis and Corresponding Genetic and Metabolic Dysregulation in Psoriasis Patients Using Metagenomics Sequencing
by: Shiju Xiao, et al.
Published: (2021-04-01) -
Chain length‐dependent inulin alleviates diet‐induced obesity and metabolic disorders in mice
by: Liangkui Li, et al.
Published: (2021-07-01) -
Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patients
by: Xinyue Zhang, et al.
Published: (2021-03-01)